FDA applicant
Vitrolife Sweden AB
FDA records 38 decisions for Vitrolife Sweden AB (Washington, DC) from 2000 to 2025: 38 510(k) clearances. Most are in product codes MQL (Media, Reproductive) and MQE (Needle, Assisted Reproduction). Since 2016 its 510(k)s took a median of 156 days from receipt to decision, against 195 for FDA’s reviews in the same codes and years. Its devices cite 27 predicates, 12 of them its own earlier devices. 1 recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Vitrolife Sweden AB’s devices, and how often a recall has named them.
FDA decisions per year
1in 2025
2026 so far, outlined.
Recalls per year
1in 2011
Class I Class II/III not classified
Planning a device like Vitrolife Sweden AB’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Vitrolife”
FDA records each applicant name separately; these may or may not be the same firm.